<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput xmlns:ns2="local" id="124309"><Title>Shionogi to market Molecular Biosystems' FS-069 against cardiovascular disease in Japan, Taiwan and South Korea</Title><Principal>Molecular Biosystems Inc</Principal><Partner>Shionogi &amp; Co Ltd</Partner><Type>Drug - Commercialization License</Type><Status>Terminated</Status></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput>